Tech Company Financing Transactions
Carbylan Therapeutics Funding Round
Private investors participated in a $4 million funding round for Carbylan Therapeutics. The round was announced on 3/6/2015.
Transaction Overview
Company Name
Announced On
3/6/2015
Transaction Type
Debt
Amount
$4,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
3181 Porter Dr.
Palo Alto, CA 94304
USA
Palo Alto, CA 94304
USA
Phone
Website
Email Address
Overview
Carbylan was founded in 2005 to develop and market medical devices and device/drug combination products
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Renzi
Chief Financial Officer
Michael White
VP - R & D
David Gravett
VP - Regulatory Affairs
Hayley Lewis
Browse more venture capital transactions:
Prev: 3/6/2015: Cerevast Therapeutics venture capital transaction
Next: 3/6/2015: Vanhawks venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs